Artificial intelligence (AI) software developer Bay Labs and medical device developer Edwards Lifesciences have announced a collaboration to apply AI to the detection of heart disease.
The companies have planned multiple projects aimed at increasing the accuracy of heart disease detection and diagnosis, particularly on echocardiograms. They plan to develop new deep-learning algorithms and integrate Bay Labs' EchoMD algorithms into Edwards' CardioCare quality care navigation platform.
